FDA Clearance Tracker · P130030
REBEL PLATINUM CHROMIUM CORONARY STENT SYSTEM MONORAIL AND OVER THE WIRE
Last checked: Nov 19, 2026Latest source record: Mar 10, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Mar 10, 2026
Approved
Time to decision
4,453 days
Received Dec 30, 2013. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P130030
- Device name
- REBEL PLATINUM CHROMIUM CORONARY STENT SYSTEM MONORAIL AND OVER THE WIRE
- Applicant
- Boston Scientific Corp
- Applicant location
- Maple Grove, MN
- Received
- Dec 30, 2013
- Decided
- Mar 10, 2026
- Decision
- Approved
- Supplements
- 75 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- STENT, CORONARY (MAF)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE REBEL PLATINUM CHROMIUM CORONARY STENT SYSTEM (MONORAIL AND OVER-THE-WIRE). THIS DEVICE IS INDICATED FOR IMPROVING CORONARY LUMINAL DIAMETER IN PATIENTS WITH DE NOVO LESIONS <= 28 MM IN LENGTH IN NATIVE CORONARY ARTERIES WITH A REFERENCE VESSEL DIAMETER (RVD) OF >= 2.25 TO >= 4.50 MM.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MAF. The earliest in FDA's data is P910030, decided Feb 8, 1993.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- WATCHMAN FLX Left Atrial Appendage (LAA) Closure Technology, WATCHMAN FLX Left Atrial Appendage Closure Device with DeliPMA supplement
P130013-S074 · Decided Jul 16, 2025 · 180 days after receipt · Panel Track
Device type: System, appendage closure, left atrial (NGV) · Cardiology
K243245 · Decided Oct 18, 2024 · 7 days after receipt
Device type: Unit, Cryosurgical, Accessories (GEH) · General & Plastic Surgery
P150031-S064 · Decided Feb 29, 2024 · 153 days after receipt · Panel Track
Device type: Stimulator, electrical, implanted, for parkinsonian symptoms (NHL) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.